Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Brian Adams

General Counsel at Kymera Therapeutics, Inc. (KYMR)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $744K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 4SEC KYMRKymera Therapeutics, Inc. Sell 1,20955,416 held (−2%) $115.55 $140K -9.3%
Sep 4SEC KYMRKymera Therapeutics, Inc. Sell 3,02552,391 held (−5%) $116.81 $353K -10.3%
Sep 4SEC KYMRKymera Therapeutics, Inc. Sell 2,13750,254 held (−4%) $117.57 $251K -10.9%